Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 4/1999

01-10-1999 | Adis Drug Evaluation

Epirubicin

A Review of its Intravesical Use in Superficial Bladder Cancer

Authors: Susan V. Onrust, Lynda R. Wiseman, Karen L. Goa

Published in: Drugs & Aging | Issue 4/1999

Login to get access
Metadata
Title
Epirubicin
A Review of its Intravesical Use in Superficial Bladder Cancer
Authors
Susan V. Onrust
Lynda R. Wiseman
Karen L. Goa
Publication date
01-10-1999
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 4/1999
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-199915040-00006

Other articles of this Issue 4/1999

Drugs & Aging 4/1999 Go to the issue

Review Article

Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients

Leading Article

Insulin-Like Growth Factor I

Disease Management

Epidemiology and Drug Treatment of Epilepsy in Elderly People

Review Article

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

Review Article

New Bisphosphonates in the Treatment of Bone Diseases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits